03847nam a22005175i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001300153050001300166050001300179072001500192072001500207072001500222072002300237072001400260072001400274072001400288245012100302250001800423264007500441300006600516336002600582337002600608338003600634347002400670505108700694520106201781650002302843650001302866650002302879650002302902650001302925650002302938700007702961700007703038710003403115773002603149776003603175776003603211776003603247856004603283978-3-031-56968-5DE-He21320251030112933.0cr nn 008mamaa240903s2024    sz |    s    |||| 0|eng d  a97830315696857 a10.1007/978-3-031-56968-52doi 4aRC1-1245 4aRC1-1245 4aRC1-1245 7aMJ2bicssc 7aMJ2bicssc 7aMJ2bicssc 7aMED0450002bisacsh 7aMJ2thema 7aMJ2thema 7aMJ2thema10aNeuroendocrine Tumoursh[electronic resource] :bDiagnosis and Management /cedited by Suayib Yalcin, Kjell Öberg.  a2nd ed. 2024. 1aCham :bSpringer International Publishing :bImprint: Springer,c2024.  aVII, 682 p. 103 illus., 66 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 a1. Introduction -- 2. Historical background -- 3. Epidemiology -- 4. Molecular biology -- 5. Genetic syndromes associated with NET -- 6. Pathological evaluation and Classification -- 7. Biomarkers -- 8. Radiological Imaging -- 9. Nuclear Imaging -- 10. Neuroendocrine Tumors of the Lung -- 11. Overview of Gastrointestinal NET -- 12. Overview of Pancreatic NET -- 13. Insulinoma -- 14. Gastrinoma -- 15. Vipoma and PPoma -- 16. Glucagonoma -- 17. Somatostatinoma -- 18. Less common types of pNET -- 19. Nonfunctional pNET -- 20. Poorly differentiated NET -- 21. Large cell NEC -- 22. MEN syndromes -- 23. Differentiated Thyroid cancer -- 24. Medullary thyroid cancer -- 25. Adrenocortical cancer -- 26. Paraganglioma, feokromostoma -- 27. Surgical Approach -- 28. Locoregional treatment (RFA) Embolization (Chemo/radio) -- 29. PRRT -- 30. Management of hormonal symptoms -- 31. Carcinoid syndrome -- 32.Somatostatin analogues and interferon -- 33. Chemotherapy -- 34. Targeted therapies -- 35. Immunotherapy in the treatment of neuroendocrine tumors -- 36. Societies and guidelines.  aThe second edition of this important textbook covers all aspects of neuroendocrine tumors (NETs), from epidemiology, pathological classification and evaluation, and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies and immunotherapies. Readers will find individual discussion of each of the various types of NET: gastrointestinal, lung, and pancreatic tumors such as insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, and non-functioning pancreatic NETs, as well as medullary thyroid carcinomas, pheochromocytomas, paragangliomas, etc. In addition to NETs, endocrine tumors such as thyroid tumors and adrenocortical tumors are also covered. The contributing authors are internationally recognized experts who bring a wealth of science and experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists, and pathologists as well as for trainees in these fields. 0aInternal medicine. 0aSurgery.14aInternal Medicine.24aInternal Medicine.24aSurgery.24aInternal Medicine.1 aYalcin, Suayib.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt1 aÖberg, Kjell.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303156967808iPrinted edition:z978303156969208iPrinted edition:z978303156970840uhttps://doi.org/10.1007/978-3-031-56968-5